Online citations, reference lists, and bibliographies.
← Back to Search

Polymer-lipid Hybrid Systems: Merging The Benefits Of Polymeric And Lipid-based Nanocarriers To Improve Oral Drug Delivery

Shasha Rao, C. Prestidge
Published 2016 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT Introduction: A number of biobarriers limit efficient oral drug absorption; both polymer-based and lipid-based nanocarriers have demonstrated properties and delivery mechanisms to overcome these biobarriers in preclinical settings. Moreover, in order to address the multifaceted oral drug delivery challenges, polymer-lipid hybrid systems are now being designed to merge the beneficial features of both polymeric and lipid-based nanocarriers. Areas covered: Recent advances in the development of polymer-lipid hybrids with a specific focus on their viability in oral delivery are reviewed. Three classes of polymer-lipid hybrids have been identified, i.e. lipid-core polymer-shell systems, polymer-core lipid-shell systems, and matrix-type polymer-lipid hybrids. We focus on their application to overcome the various biological barriers to oral drug absorption, as exemplified by selected preclinical studies. Expert opinion: Numerous studies have demonstrated the superiority of polymer-lipid hybrid systems to their non-hybrid counterparts in providing improved drug encapsulation, modulated drug release, and improved cellular uptake. These features have encouraged their applications in the delivery of chemotherapeutics, proteins, peptides, and vaccines. With further research expected to optimize the manufacturing and scaling up processes and in-depth pre-clinical pharmacological and toxicological assessments, these multifaceted drug delivery systems will have significant clinical impact on the oral delivery of pharmaceuticals and biopharmaceuticals.
This paper references
10.1021/nn900002m
Impact of nanotechnology on drug delivery.
O. Farokhzad (2009)
10.1002/anie.201200409
Hybrid nanomaterials that mimic the food effect: controlling enzymatic digestion for enhanced oral drug absorption.
A. Tan (2012)
10.1246/CL.2012.1334
Nanostructured Silica–Lipid Hybrid Microparticles: A Supersaturating Carrier for Water- and Lipid-resistant Compounds
A. Tan (2012)
10.1080/02652040802383839
Preparation and evaluation of celecoxib-loaded microcapsules with self-microemulsifying core
M. Homar (2009)
10.1021/mp300649z
Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
H. Yuan (2013)
10.1016/j.drudis.2011.11.007
Bridging solubility between drug discovery and development.
Li Di (2012)
10.1007/s11095-013-1126-0
Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway
H. Williams (2013)
Reviews the fate of polymeric nanoparticles following oral drug delivery
10.1021/LA047659T
Physicochemical and interfacial investigation of lipid/polymer particle assemblies.
Anne-Lise Troutier (2005)
10.1021/nn200478m
Triggered release of pharmacophores from [Ni(HAsO₃)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: a combined experimental and theoretical study.
S. Lee (2011)
10.1016/j.ijpharm.2014.06.052
M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity.
Tongtong Ma (2014)
10.1016/j.jconrel.2014.07.037
'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
O. Feeney (2014)
10.3109/08982104.2011.621128
Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin
H. Sugihara (2012)
10.1021/mp300164u
Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.
M. U. Anby (2012)
10.1016/J.COCIS.2010.12.005
Fate of polymeric nanocarriers for oral drug delivery
L. Plapied (2011)
10.1124/PR.112.005660
Strategies to Address Low Drug Solubility in Discovery and Development
H. Williams (2013)
10.1016/J.COLSURFA.2004.10.058
A study on the interactions of surfactants with phospholipid/polydiacetylene vesicles in aqueous solutions
Y. Su (2005)
10.1016/J.JCONREL.2006.08.013
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
A. des Rieux (2006)
10.1016/J.COLSURFB.2005.12.011
Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
Jian You (2006)
10.1016/S0928-0987(98)00032-3
Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems.
M. Marvola (1999)
10.3109/1061186X.2010.525652
Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility
D. B. Warren (2010)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.1016/j.biomaterials.2008.12.013
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
J. M. Chan (2009)
10.1039/9781849735292-00063
Chapter 2.2:NANOSTRUCTURES OVERCOMING THE INTESTINAL BARRIER: DRUG DELIVERY STRATEGIES
K. Ryan (2012)
10.1016/j.ejpb.2009.06.001
Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
S. Chakraborty (2009)
10.1016/j.colsurfb.2011.02.033
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Wean Sin Cheow (2011)
10.1016/S0378-5173(03)00158-3
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
H. Li (2003)
Doxil® – the first FDA-approved nano-drug. In: Peer D, editor. Handbook of harnessing biomaterials in nanomedicine
CB Yechezkel (2012)
10.1002/anie.200803526
Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier.
Y. Wang (2008)
10.1016/J.DRUDIS.2006.08.005
Is the oral route possible for peptide and protein drug delivery?
M. Morishita (2006)
Discusses the role of lipids in the oral delivery of poorly water soluble compounds
10.1016/j.ijpharm.2013.05.013
Drug precipitation inhibitors in supersaturable formulations.
Sen Xu (2013)
10.1039/9781849735292-00039
Chapter 2.1:Nanostructures Overcoming the Intestinal Barrier: Physiological Considerations and Mechanistic Issues
S. Maher (2012)
10.1016/j.ejpb.2015.01.022
Nano-carrier systems: Strategies to overcome the mucus gel barrier.
S. Dünnhaupt (2015)
10.1016/S0169-409X(01)00149-1
Exploiting M cells for drug and vaccine delivery.
M. A. Clark (2001)
10.1021/mp9002442
Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems.
A. Tan (2010)
10.1021/ja107333g
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
S. Lee (2010)
10.1016/S0928-0987(02)00030-1
High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes.
Ruzica Galović Rengel (2002)
Nanostructures overcoming the intestinal barrier: physiological considerations andmechanistic issues
S Maher (2012)
10.1016/j.ijpharm.2009.12.055
Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide.
A. Zvonar (2010)
10.1016/j.colsurfb.2014.02.039
PLGA-lipid liposphere as a promising platform for oral delivery of proteins.
Tongtong Ma (2014)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1016/j.ijpharm.2008.11.013
Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
M. Werle (2009)
10.1007/s11095-013-1107-3
Transforming Lipid-Based Oral Drug Delivery Systems into Solid Dosage Forms: An Overview of Solid Carriers, Physicochemical Properties, and Biopharmaceutical Performance
A. Tan (2013)
10.1021/la103576a
Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method.
R. Fang (2010)
10.1016/S0378-5173(97)00237-8
Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract
K. Iwanaga (1997)
10.1016/j.nano.2008.08.003
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Rishi Paliwal (2009)
10.3109/10717544.2011.596585
N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin
Aiwen Huang (2011)
10.1016/J.CARBPOL.2010.12.042
Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system
B. Sarmento (2011)
10.1016/j.ijpharm.2014.11.047
Improved insulin loading in poly(lactic-co-glycolic) acid (PLGA) nanoparticles upon self-assembly with lipids.
M. Garcia-Diaz (2015)
10.3109/03639049009074381
Effects of Gastrointestinal Administration of Human Insulin and a Human Insulin-Deae-Dextran Complex Entrapped in Different Compound Liposomes on Blood Glucose in Rats
A. Manosroi (1990)
10.1016/J.JCONREL.2005.11.011
Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
M. Werle (2006)
10.1038/nrd2197
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1016/j.jconrel.2014.05.013
Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
Shasha Rao (2014)
10.1016/J.COLSURFA.2010.08.050
Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods
Wean Sin Cheow (2010)
10.1016/J.IJPHARM.2004.10.005
A novel formulation design about water-insoluble oily drug: preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits.
Jian You (2005)
10.1007/s12272-013-0011-z
Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation
W. Song (2013)
10.1023/A:1016214332030
In Vitro Evaluation of Polymerized Liposomes as an Oral Drug Delivery System
J. Okada (2004)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/J.ADDR.2005.07.001
The basics and underlying mechanisms of mucoadhesion.
J. Smart (2005)
10.1039/9781849735292-00003
Chapter 1:Historical View of the Design and Development of Nanocarriers for Overcoming Biological Barriers
M. Alonso (2012)
10.1016/J.EJPS.2006.04.016
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
C. Pouton (2006)
10.1016/j.ddtec.2011.12.001
Overcoming poor oral bioavailability using nanoparticle formulations - opportunities and limitations.
Preshita P Desai (2012)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1002/jps.21659
Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.
K. Mohsin (2009)
10.1080/02652040601058525
Preparation of microcapsules with self-microemulsifying core by a vibrating nozzle method
M. Homar (2007)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
10.1016/j.ijpharm.2014.04.027
Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
A. Beloqui (2014)
10.1016/J.IJPHARM.2007.05.006
Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
Roger Vandecruys (2007)
10.1016/S0168-3659(03)00093-2
Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity.
Seiichiro Minato (2003)
10.1039/c3cs60299k
Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.
K. Raemdonck (2014)
10.1002/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO;2-R
Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.
W. Charman (2000)
10.1158/0008-5472.CAN-10-3118
High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation.
T. Nassar (2011)
10.1007/s11095-010-0130-x
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
G. Fricker (2010)
10.1002/jps.21451
Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
Ping Gao (2009)
10.1016/S0928-4931(02)00017-6
Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol
Si Shen Feng (2002)
10.1002/anie.200902672
Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.
Katrin Knop (2010)
10.1002/ANIE.198009381
Polymerizable phospholipid analogues--new stable biomembrane and cell models.
H. Hub (1980)
10.1016/J.JCONREL.2005.05.022
An enteric-coated dry emulsion formulation for oral insulin delivery.
Eiichi Toorisaka (2005)
10.1016/S0378-5173(03)00254-0
Chitosan-coated liposomes: characterization and interaction with leuprolide.
J. Guo (2003)
10.1007/s13346-011-0023-5
Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin
P. Fonte (2011)
10.1016/j.ijpharm.2010.05.008
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Y. Liu (2010)
Polymerized Vesicles 의 투과 특성
조의환 (1991)
10.1517/17425247.2011.547469
Lipid-based oral multiparticulate formulations – advantages, technological advances and industrial applications
Dali Shukla (2011)
10.1016/j.jconrel.2008.10.014
Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
A. Tan (2009)
10.2217/nnm.14.177
Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration.
H. Harde (2015)
10.1016/S1359-6446(05)03575-0
PEGylation, successful approach to drug delivery.
F. Veronese (2005)
10.1016/J.ADDR.2007.10.010
Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
C. Pouton (2008)
10.1016/j.carbpol.2014.12.084
Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Y. Luo (2015)
10.1208/s12249-010-9528-3
Enteric Micro-Particles for Targeted Oral Drug Delivery
A. Dalmoro (2010)
10.1002/jps.23914
Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Rokhsana Yasmin (2014)
10.1016/J.CARBPOL.2011.01.037
Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin
Xiaoying Ying (2011)
10.1016/0168-3659(96)01459-9
Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability
Hongming Chen (1996)
10.1016/j.jconrel.2012.03.020
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
10.1081/DDC-120028718
Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations
Ping Gao (2004)
10.1016/j.biomaterials.2013.08.048
Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
X. Li (2013)
10.1002/JPS.10511
Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability.
Ping Gao (2003)
10.1021/acsami.5b05068
Bioactive Hybrid Particles from Poly(D,L-lactide-co-glycolide) Nanoparticle Stabilized Lipid Droplets.
P. Joyce (2015)
10.1021/nn800275r
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
L. Zhang (2008)
10.1016/j.drudis.2014.09.018
Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Deepti Pandita (2015)
10.1201/B11620
Handbook of Harnessing Biomaterials in Nanomedicine : Preparation, Toxicity, and Applications
D. Peer (2012)
• Demonstrates the ability of various nanostructured solid carriers to influence lipid-based drug delivery system biopharmaceutical performance
10.1023/A:1016030202104
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Hongming Chen (2004)
10.1021/la9034112
A promising drug controlled-release system based on diacetylene/phospholipid polymerized vesicles.
Caixin Guo (2009)
10.1073/pnas.1313839110
Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption
Suha Attili-Qadri (2013)
10.1016/S0168-3659(02)00411-X
Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
H. Takeuchi (2003)
10.1021/CG4015256
Effects of polymer and surfactant on the dissolution and transformation profiles of cocrystals in aqueous media
Amjad Alhalaweh (2014)
10.1016/j.ijpharm.2015.02.055
Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
F. Yu (2015)
10.1016/j.ijpharm.2014.11.060
Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS).
D. Lee (2015)
10.1021/la9008174
Modulating pancreatic lipase activity with galactolipids: effects of emulsion interfacial composition.
B. Chu (2009)
10.1016/J.COLSURFA.2006.01.034
The study of the emulsification efficiency of Aerosil and HPMCAS type and their ratio to stabilize emulsions of zedoary turmeric oil
Jian You (2006)
10.1016/j.ejps.2013.10.015
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
Christel A S Bergström (2014)
10.1016/S0074-7696(08)61346-7
M cells in Peyer's patches of the intestine.
A. Gebert (1996)
10.1016/j.colsurfb.2012.01.001
Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Vinay Kumar Venishetty (2012)
10.1021/nn100560p
Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapy.
S. Lee (2010)
10.1007/s11095-008-9562-y
Role of Particle Size in Phagocytosis of Polymeric Microspheres
J. Champion (2008)
10.1016/J.IJPHARM.2005.06.028
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
H. Takeuchi (2005)
10.1016/j.biomaterials.2009.01.005
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.
Carolina Salvador-Morales (2009)
10.1016/j.ejpb.2010.12.008
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Abdallah Makhlof (2011)
10.1007/s13346-013-0172-9
First in man bioavailability and tolerability studies of a silica–lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen
A. Tan (2013)
10.1021/JA070748I
Polymer-caged lipsomes: a pH-responsive delivery system with high stability.
S. Lee (2007)
10.1016/j.biomaterials.2012.05.026
Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
S. Jain (2012)
10.1016/j.ijpharm.2008.03.030
Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.
F. Wan (2008)
10.1016/S0264-410X(01)00258-4
Targeting polymerised liposome vaccine carriers to intestinal M cells.
M. A. Clark (2001)
10.1208/s12248-015-9824-7
Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems
Tahnee J. Dening (2015)
10.1021/mp300202c
Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes).
S. Jain (2012)
10.2217/nnm.14.37
Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
Shasha Rao (2014)
10.1021/acs.molpharmaceut.5b00622
Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Shasha Rao (2015)
10.1002/JPS.20906
Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
Héctor R Guzmán (2007)
10.1002/jps.24067
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system.
H. Williams (2014)
10.1016/j.jconrel.2013.10.011
Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats☆
K. Gradauer (2013)
10.1016/j.addr.2011.12.009
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Laura M Ensign (2012)
10.1007/s11095-013-1190-5
PLGA/Liposome Hybrid Nanoparticles for Short-Chain Ceramide Delivery
P. Zou (2013)
10.1016/J.COLSURFB.2005.08.005
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
F. Hu (2005)
10.1023/A:1015345827091
The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers
A. Clausen (2004)



This paper is referenced by
10.1080/17425247.2019.1605353
An update on polymer-lipid hybrid systems for improving oral drug delivery
Sajedehsadat Maghrebi (2019)
10.1016/B978-0-12-820658-4.00013-3
Inhalable hybrid nanocarriers for respiratory disorders
P. Maurya (2020)
10.4018/978-1-5225-4781-5.CH017
Emergence of Polymer-Lipid Hybrid Systems in Healthcare Scenario
Anamika Jain (2018)
10.1208/s12249-016-0657-1
Paliperidone-Loaded Nanolipomer System for Sustained Delivery and Enhanced Intestinal Permeation: Superiority to Polymeric and Solid Lipid Nanoparticles
Hala Mahmoud Helal (2016)
Polymer and Lipid-based Nanomedicine of Synergistic Drug Combination for Improving Chemotherapy of Multidrug Resistant Breast Cancer
Rui Xue Zhang (2016)
10.1002/ADFM.201802136
Hybrid Vesicular Drug Delivery Systems for Cancer Therapeutics
M. Mohammadi (2018)
10.1186/s11671-019-3241-2
Advances of Nano-Structured Extended-Release Local Anesthetics
Yumiao He (2020)
10.3390/ijms19051361
Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit®-Containing Liposomes
Elisabet Martí Coma-Cros (2018)
10.1016/J.JDDST.2017.09.006
Lipid and PLGA hybrid microparticles as carriers for protein delivery
Chengyu Wu (2018)
10.5530/ijper.54.2s.59
Lipid Nanocarriers: Promising Approach for Oral Drug Delivery System
V. Yadav (2020)
10.3390/polym12051003
Recent Advances in Hybrid Biomimetic Polymer-Based Films: from Assembly to Applications
Agata Krywko-Cendrowska (2020)
10.1016/j.smim.2017.07.007
Murine models for mucosal tolerance in allergy.
U. Smole (2017)
10.1021/ACSMACROLETT.7B00035
Noncompetitive Active Transport Exploiting Intestinal Transferrin Receptors for Oral Delivery of Proteins by Tunable Nanoplatform
R. Ganugula (2017)
10.1016/J.JDDST.2017.02.011
Optimization of formulation processes using Design Expert® Software for preparation of polymeric blends-artesunate-amodiaquine HCl microparticles
J. D. Ogbonna (2017)
10.1016/j.ejpb.2019.07.010
In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
Chengyu Wu (2019)
10.1016/j.jconrel.2017.11.015
Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer‐lipid hybrid nanoparticles
Tianyang Ren (2018)
10.4103/1735-5362.235156
Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
Parisa Ghasemiyeh (2018)
10.1016/j.drudis.2017.01.011
How can nanoparticles contribute to antituberculosis therapy?
J. Costa-Gouveia (2017)
10.1186/s12951-020-00619-0
Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice
Xiaoyan Bao (2020)
10.1021/acs.molpharmaceut.7b00503
Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.
Jingxin Gou (2017)
10.1007/s11051-020-04990-9
Tamoxifen-loaded PLA/DPPE-PEG lipid-polymeric nanocapsules for inhibiting the growth of estrogen-positive human breast cancer cells through cell cycle arrest
Niloofar Behdarvand (2020)
10.1016/j.msec.2017.04.113
Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin.
Bin Xu (2017)
10.1080/00914037.2017.1300900
Lipid polymer hybrid carrier systems for cancer targeting: A review
Z. Chaudhary (2018)
10.2174/1568009620666200115160805
Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
Kuldeep Rajpoot (2020)
10.1039/c6nr08486a
Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
R. Zhang (2017)
10.1016/j.ejpb.2016.06.016
Freeze-dried eudragit-hyaluronan multicompartment liposomes to improve the intestinal bioavailability of curcumin.
Ana Catalan-Latorre (2016)
10.3390/polym10010031
Polymer-Based Nanomaterials and Applications for Vaccines and Drugs
J. Han (2018)
10.1038/s41598-019-56320-2
Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats
E. Abdou (2019)
10.1016/j.nano.2017.05.003
Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.
Ying Liu (2017)
10.1016/j.matdes.2020.108805
Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
Jana Ghitman (2020)
Semantic Scholar Logo Some data provided by SemanticScholar